IL-2 Antibodies in Type 1 Diabetes and During IL-2 Therapy

Diabetologia - Germany
doi 10.1007/s00125-018-4649-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Lobular Panniculitis After Subcutaneous Administration of Interleukin-2 (IL-2), and Its Exacerbation During Intravenous Therapy With IL-2

British Journal of Cancer
Cancer ResearchOncology
1992English

Internalization of Interleukin 1 (IL 1) Correlates With IL 1-Induced IL 2 Receptor Expression and IL 2 Secretion of EL4 Thymoma Cells

European Journal of Immunology
AllergyImmunology
1989English

Role of IL-1β Modifications in Older Patients With Type 2 Diabetes

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Targeting IL-2 Receptors for Diagnosis and Therapy

Japanese Journal of Clinical Immunology
1994English

Serum Levels of Interleukin 10 (IL-10) in Patients With Type 2 Diabetes

Clinical Biochemistry
MedicineClinical Biochemistry
2011English

Interleukin 2 (IL-2) Augments Transcription of the IL-2 Receptor Gene.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Theranostic Evaluation of the Combination of Hypofractionated Radiation Therapy and IL-2/anti-IL-2 Complexes in Tumor-Bearing Mice

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

IL-10 Dependent Suppression of Type 1, Type 2 and Type 17 Cytokines in Active Pulmonary Tuberculosis

PLoS ONE
Multidisciplinary
2013English

IL-2; IL-2 Receptor Α-Chain (IL2-RA; CD25); IL-2 Receptor Β-Chain (IL2-RB; CD122)

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy